[Antidementia drugs--who has the benefit?]

Internist (Berl). 2008 Jun;49(6):761-2; author reply 762. doi: 10.1007/s00108-008-2160-6.
[Article in German]
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cholinesterase Inhibitors / adverse effects
  • Cholinesterase Inhibitors / therapeutic use*
  • Clinical Trials as Topic
  • Dementia / drug therapy*
  • Dementia / etiology
  • Humans
  • Nootropic Agents / adverse effects
  • Nootropic Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Nootropic Agents